One-Year Late Lumen Loss between A Polymer-Coated Paclitaxel-Eluting Stent (Eluvia) and a Polymer-Free Paclitaxel-Coated Stent (Zilver PTX) for Femoropopliteal Disease

Aim: Paclitaxel-eluting stents' (Eluvia and Zilver PTX) effectiveness has been recently reported for femoropopliteeal (FP) lesions. However, there is no evaluation of one-year late lumen loss (LLL). Therefore, we evaluated one-year LLL after implantation with Eluvia or Zilver PTX.Methods: This...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of Atherosclerosis and Thrombosis 2020/02/01, Vol.27(2), pp.164-171
Hauptverfasser:	Soga, Yoshimitsu, Fujihara, Masahiko, Tomoi, Yusuke, Iida, Osamu, Ishihara, Takayuki, Kawasaki, Daizo, Ando, Kenji
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiovascular System & Cardiology Drug-eluting stent Endovascular therapy Femoropopliteal disease Life Sciences & Biomedicine Original Peripheral Vascular Disease Science & Technology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!